ImmunoGen, Inc. Announces Webcast Of Presentations At Upcoming Investor Conferences

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:
  • Cowen and Company 34 th Annual Health Care Conference9:20 am ET, March 4 in Boston, MA
  • 26 th Annual ROTH Conference12:00 pm PT (3:00 pm ET), March 11 in Laguna Niguel, CA

The webcasts will be accessible live through the “Investor Information” section of the Company’s website, www.immunogen.com; a replay will be available for approximately a week.

About ImmunoGen, Inc.

ImmunoGen, Inc. develops targeted anticancer therapeutics. The Company’s ADC technology uses a tumor-targeting engineered antibody to deliver one of ImmunoGen's highly potent cancer-cell killing agents specifically to tumor cells; the Company has also developed antibodies with anticancer activity of their own. The most advanced compound with ImmunoGen’s ADC technology is Roche’s Kadcyla ®. Additional compounds are in clinical testing by ImmunoGen and through the Company’s partnerships with Amgen, Bayer HealthCare, Biotest and Sanofi. More information about ImmunoGen can be found at www.immunogen.com.

Kadcyla ® is a registered trademark of Genentech, Inc., a member of the Roche Group.

Copyright Business Wire 2010

If you liked this article you might like

Stock Futures Hold Higher After U.S. Adds 261,000 in October

Stock Futures Hold Higher After U.S. Adds 261,000 in October

Acorda Shares Down on FDA's 'Refusal to File' Letter - Biotech Movers

Acorda Shares Down on FDA's 'Refusal to File' Letter - Biotech Movers

Amazon Falls, Obamacare Repeal Fails - 5 Things You Must Know Before the Market Opens

Amazon Falls, Obamacare Repeal Fails - 5 Things You Must Know Before the Market Opens

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead
7 Stocks Under $10 Making Big Up Moves

7 Stocks Under $10 Making Big Up Moves